Replies to post #484069 on Anavex Life Sciences Corp (AVXL)

[LakeshoreLeo1953]

Conviction is great unless unrealistic.
There will be additional trial(s) of Blarcamesine whether required contingent
to approval or back to the drawing board if current results prove inadequate.

While a more nuanced view it is the better bet.

[Investor2014]

I don't think that our chance of EMA approval is bullxxxx at all. Nor do I think that that approval is a given from the existing AD trials data for A2-73. We have seen before with the EXCELLENCE trial outcome that being too categoric on either side of the equation is not a sensible approach.